| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fb7bbc09927d64558e1e99a3b7c719b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-14 |
| filingDate |
2011-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41305cbaf6ae278fde8caf4446c29813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3816e1c86cbaaa8d03c80f1095c1377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d9452bc480d64edf211dffd3c62de11 |
| publicationDate |
2018-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180110163-A |
| titleOfInvention |
Integrin-linked kinase inhibitors |
| abstract |
The present invention relates to the use of such compounds in a method of treating or preventing cancer in a subject by administering to the subject a pharmaceutical composition comprising a plurality of compounds and a compound of formula (I) or a pharmaceutically acceptable salt thereof . The compounds may also be used to inhibit intracellular integrin-binding kinases acting on the Akt signaling pathway. |
| priorityDate |
2010-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |